Results 181 to 190 of about 17,598 (244)

Multiorgan Peripheral T-Cell Lymphoma Presenting as Isolated Cardiomyopathy. [PDF]

open access: yesJACC Case Rep
Memon AA   +9 more
europepmc   +1 more source

Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration

Pharmacotherapy, 2021
Recommendations regarding vancomycin dosing in critically ill patients on continuous venovenous hemofiltration (CVVH) are limited. The purpose of this study was to evaluate current dosing practices of pharmacists for patients treated with CVVH, develop ...
Krista A Wahby   +4 more
semanticscholar   +1 more source

Anticlogging Hemofiltration Device for Mass Collection of Circulating Tumor Cells by Ligand-Free Size Selection.

Langmuir, 2021
A new hemofiltration system was developed to continuously capture circulating tumor cells (CTCs) from a large volume of whole blood using a column that was packed with antifouling zwitterionized silica microspheres.
Tzu-Hsien Wu   +3 more
semanticscholar   +1 more source

Adsorption kinetics of high mobility group box 1 protein in a polyacrylonitrile hemofiltration membrane

Therapeutic apheresis and dialysis, 2020
The high mobility group box 1 protein (HMGB1) is recognized as a prototypical endogenous danger cytokine in sepsis. We previously reported that a polyacrylonitrile (AN69ST) membrane rapidly adsorbed HMGB1.
Tomoyuki Nakamura   +7 more
semanticscholar   +1 more source

High volume hemofiltration

Current Opinion in Critical Care, 2000
The use of continuous hemofiltration has increased dramatically since its first description in 1977. It is now the dominant form of renal replacement therapy in Australia and is fast reaching a similar status in many European countries. Its growing use and the frequent observation of its beneficial effects in septic patients has directed the attention ...
Bellomo R, Baldwin I, Ronco C
openaire   +3 more sources

Home - About - Disclaimer - Privacy